Acute COPD exacerbations and in-hospital treatment-related problems: An observational study
- PMID: 38843229
- PMCID: PMC11156384
- DOI: 10.1371/journal.pone.0305011
Acute COPD exacerbations and in-hospital treatment-related problems: An observational study
Abstract
Background: Treatment-related problems (TRPs) interfere with the ability to attain the desired goals of treatment, adding cost to healthcare systems. Patients hospitalized with acute conditions are at particular risk to experience TRPs. Data investigating such burden in patients with acute exacerbation of COPD (AECOPD) is generally scarce with no studies ever conducted in Jordan. This study aimed to investigate and categorize TRPs among patients hospitalized with AECOPD in Jordan, and to estimate their cost savings and cost avoidance.
Methods: This was a retrospective population-based cohort study. Patients' cases of AECOPD admitted to the study site from Jan 2017 to Jul 2021 were identified from the electronic clinical database and screened for eligibility. TRPs were identified/categorized using AbuRuz tool and assessed for their severity. Cost saving was estimated by calculating all the extra costs. Cost avoidance was estimated according to Nesbit method.
Results: A total of 1243 (mean±SD 3.1±1.5) and 503 (mean±SD 1.3±1.2) TRPs were identified during hospitalization and at discharge respectively, of which 49.4% and 66.7% were classified as "unnecessary drug therapy". In 54.5% of the cases, systemic corticosteroid was administered for a period longer than recommended. Most of the TRPs were of moderate severity. The total direct cost saving, and cost avoidance were estimated to be 15,745.7 USD and 340,455.5 USD respectively.
Conclusion: The prevalence and cost of TRPs among AECOPD patients is a concern requiring attention. The study results implicate integrating interventions such as embracing clinical pharmacists' role in the respiratory care units to optimize patients' management.
Copyright: © 2024 Awwad et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
The Author(s) declared that there is no conflict of interest.
Figures






Similar articles
-
The Identification and Cost of Acute Chronic Obstructive Pulmonary Disease Exacerbations in a United States Population Healthcare Claims Database.COPD. 2020 Oct;17(5):499-508. doi: 10.1080/15412555.2020.1817357. Epub 2020 Sep 23. COPD. 2020. PMID: 32962447
-
Clinical factors affecting the direct cost of patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease.Int J Med Sci. 2012;9(4):285-90. doi: 10.7150/ijms.4039. Epub 2012 Jun 5. Int J Med Sci. 2012. PMID: 22701335 Free PMC article.
-
Direct Hospitalization Cost of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Vietnam.Int J Environ Res Public Health. 2018 Dec 30;16(1):88. doi: 10.3390/ijerph16010088. Int J Environ Res Public Health. 2018. PMID: 30598020 Free PMC article.
-
Economic Burden of Chronic Obstructive Pulmonary Disease (COPD): A Systematic Literature Review.Int J Chron Obstruct Pulmon Dis. 2020 Feb 26;15:439-460. doi: 10.2147/COPD.S234942. eCollection 2020. Int J Chron Obstruct Pulmon Dis. 2020. PMID: 32161455 Free PMC article.
-
The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review.COPD. 2010 Jun;7(3):214-28. doi: 10.3109/15412555.2010.481697. COPD. 2010. PMID: 20486821 Review.
Cited by
-
A retrospective analysis of the pharmacovigilance data registry in a tertiary teaching hospital in Jordan.J Pharm Policy Pract. 2024 Jul 23;17(1):2378461. doi: 10.1080/20523211.2024.2378461. eCollection 2024. J Pharm Policy Pract. 2024. PMID: 39049906 Free PMC article.
-
Perceptions and practices of community pharmacists towards the use of short-acting beta-2 agonists inhalers in Malaysia: A cross-sectional survey.PLoS One. 2025 Jun 11;20(6):e0324982. doi: 10.1371/journal.pone.0324982. eCollection 2025. PLoS One. 2025. PMID: 40498713 Free PMC article.
-
Knowledge, Attitudes, and Practices of Healthcare Providers Towards Advance Directive for COPD Patients in Riyadh, Saudi Arabia.Healthcare (Basel). 2025 Mar 30;13(7):771. doi: 10.3390/healthcare13070771. Healthcare (Basel). 2025. PMID: 40218068 Free PMC article.
References
-
- Assiri GA, Shebl NA, Mahmoud MA, et al.. What is the epidemiology of medication errors, error-related adverse events and risk factors for errors in adults managed in community care contexts? A systematic review of the international literature. BMJ open. 2018;8(5):e019101. doi: 10.1136/bmjopen-2017-019101 - DOI - PMC - PubMed
-
- Abu Farha R, Awwad O, Abdurazaq B, et al.. Evaluation of drug use pattern in adults’ outpatient clinics in a tertiary teaching hospital using WHO core prescribing indicators. Journal of Pharmaceutical Health Services Research. 2022;13(4):357–63.
-
- American Society of Hospital Pharmacists. ASHP statement on pharmaceutical care. American Journal of Hospital Pharmacy. 1993;50:1720–3. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical